Myokine signaling degradation is the pathological reduction in the synthesis, secretion, or receptor sensitivity of myokines, which are beneficial signaling proteins released by contracting skeletal muscle. These myokines act as critical communication molecules, influencing metabolism, immunity, and organ function throughout the body. Degradation of this signaling pathway, often seen with sarcopenia or physical inactivity, compromises the protective and anti-inflammatory effects of muscle on distant tissues. Restoring robust myokine signaling is a therapeutic goal for improving systemic metabolic health.
Origin
The term combines “myokine,” derived from the Greek words myo (muscle) and kinos (movement/signal), with “signaling degradation,” denoting a decline in the quality of the communication pathway. This concept highlights the role of skeletal muscle not just as a structural element but as a crucial endocrine organ.
Mechanism
Degradation is primarily driven by a lack of mechanical stimulus and the subsequent decrease in PGC-1alpha activity within the muscle fiber, which is a key transcriptional regulator for many myokines. Furthermore, chronic low-grade inflammation associated with sedentary behavior can impair the ability of target tissues, such as the liver or adipose tissue, to respond effectively to the myokine signals. This results in a loss of muscle-to-organ cross-talk, contributing to systemic insulin resistance and chronic disease states.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.